Chris Heery

Christopher Heery is a highly experienced medical professional currently serving as Chief Medical Officer at Arcellx, Inc., responsible for medical oversight, clinical strategy, medical affairs, and regulatory strategy. With over 10 years in drug development, Christopher specializes in immuno-oncology, including off-the-shelf therapeutics and cell therapies. Christopher holds board positions with Medikine, Inc., and the Chordoma Foundation, and serves on the medical advisory board of Inceptor Bio. Previous roles include Chief Medical Officer at Precision BioSciences, Chief Medical Officer at Bavarian Nordic, and leadership positions at the National Cancer Institute. Christopher completed medical training at East Carolina University and holds a B.A. from Duke University.